O. Oyeneyin

Computational design and AI driven discovery of anaplastic lymphoma kinase inhibitors for non small cell lung cancer treatment

Artificial intelligence and computational techniques employed to screen a library of ALK tyrosine kinase inhibitors, retrieved from ChEMBL database, suggest that briga_15 and crizo_35 are promising leads warranting further optimization, synthesis, and biological evaluation.